Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126256011 | 12625601 | 1 | I | 20160728 | 20160805 | 20160805 | EXP | JP-GLAXOSMITHKLINE-JP2016JPN109799 | GLAXOSMITHKLINE | 0.00 | M | Y | 0.00000 | 20160805 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126256011 | 12625601 | 1 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 250 ?G, BID | U | 0 | 250 | UG | INHALATION POWDER | BID | |||||
| 126256011 | 12625601 | 2 | PS | Flutide | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 200 ?G, BID | U | 20833 | 200 | UG | INHALATION POWDER | BID | |||||
| 126256011 | 12625601 | 3 | SS | SEREVENT DISKUS | SALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | UNK, BID | U | 0 | INHALATION POWDER | BID | |||||||
| 126256011 | 12625601 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126256011 | 12625601 | 1 | Emphysema |
| 126256011 | 12625601 | 2 | Emphysema |
| 126256011 | 12625601 | 3 | Emphysema |
| 126256011 | 12625601 | 4 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126256011 | 12625601 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126256011 | 12625601 | Inappropriate schedule of drug administration | |
| 126256011 | 12625601 | Oesophageal candidiasis | |
| 126256011 | 12625601 | Off label use | |
| 126256011 | 12625601 | Oropharyngeal candidiasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126256011 | 12625601 | 1 | 200808 | 0 | ||
| 126256011 | 12625601 | 2 | 200302 | 0 | ||
| 126256011 | 12625601 | 3 | 200302 | 0 |